[Glycopyrrolate (Robinul), a new anticholinergic substance]

Area of Science:

• Pharmacology
• Anesthesiology

Context:

• Glycopyrrolate is a quaternary ammonium compound used similarly to atropine.
• Its quaternary structure limits oral absorption and barrier penetration (placental, blood-brain).

Purpose:

• To compare the efficacy and safety of glycopyrrolate with atropine in various clinical applications, particularly in anesthesia.

Summary:

• Parenteral glycopyrrolate exhibits twice the cardio-vagal blocking action and 5-6 times greater salivation inhibition compared to atropine.
• It offers a 2-3 times wider therapeutic margin for premedication.
• Glycopyrrolate is advantageous with neostigmine for antagonizing neuromuscular blockade due to better pharmacodynamic synergy.
• It effectively inhibits bradycardia during anesthesia, especially with repeated succinylcholine doses.
• Provides prolonged bronchodilation via smooth muscle blockade, though gastric alkalinization is unverified.
• Limited pediatric studies suggest no significant advantage over atropine in pediatric anesthesia.

Impact:

• Glycopyrrolate presents a favorable alternative to atropine in specific anesthetic and neuromuscular blockade reversal scenarios.
• Its distinct pharmacokinetic and pharmacodynamic profile offers enhanced safety and efficacy in certain patient populations.
• Further research is needed to fully elucidate its role in pediatric anesthesia.